Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
阐明肝脏 mTORC2 作为碳水化合物代谢关键调节因子在非酒精性脂肪肝中的作用
基本信息
- 批准号:10387520
- 负责人:
- 金额:$ 3.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:ATP Citrate (pro-S)-LyaseAblationAcetatesAcetyl Coenzyme AAcuteAddressAffectAmericanAuxinsBrown FatCarbohydratesCellsCirrhosisComplexConsumptionDeveloped CountriesDeveloping CountriesDietDoseEndocrineEnzymesFDA approvedFRAP1 geneFastingFatty LiverFatty acid glycerol estersFructoseGluconeogenesisGlucoseGlycogenGoalsHepaticHepatocyteHigh Fat DietHomeostasisHumanImpairmentLeadLife StyleLinkLipidsLiverMetabolicMetabolic DiseasesMetabolismModernizationMolecular BiologyMusNuclearNutrientObesityOrganPathogenesisPathologicPathologyPathway interactionsPersonsPhosphorylationPlantsPrevalencePrimary carcinoma of the liver cellsProcessProductionProteomicsRegulationRoleSignal TransductionSystemTestingTimeWorkbasecarbohydrate metabolismclinically relevantcostdietary supplementsfightingflexibilitylipid biosynthesislipid metabolismliver transplantationmetabolomicsneglectnon-alcoholic fatty liver diseasenonalcoholic steatohepatitisnovel therapeuticsprotective effectresponsestandard of caresugar
项目摘要
Project Summary
Non-alcoholic fatty liver disease (NAFLD) currently effects around 30% of Americans and costs the U.S
approximately $103 billion annually. However, the standard of care remains lifestyle changes and liver
transplantation with currently no FDA approved therapies. NAFLD often correlates with obesity which is rising
in both developed and developing nations. Mammalian target of rapamycin complex 2 (mTORC2) is emerging
as a central hub for carbohydrate and lipid metabolism, with its activation having been linked to NAFLD in
mice. These recent studies have highlighted a role for mTORC2 modulation during high-fat diets in mice,
where hepatic mTORC2 ablation provides a protective effect against high-fat induced hepatic steatosis.
However, the dietary supplements that have been most attributed to the rise of NAFLD in humans are
carbohydrates, specifically fructose. While protective effects of mTORC2 ablation in the liver during high-fat
diet have been investigated, its impact on high-carbohydrate diets has been neglected. Here, I will examine the
ability for mTORC2 to protect against high-carbohydrate induced hepatic steatosis, as has previously been
seen in the context of high-fat diets. Mechanistically, I will investigate the role by which hepatic mTORC2
regulates carbohydrate derived acetyl-CoA synthesis and utilization, subsequently promoting the pathogenesis
of NAFLD. I will accomplish this by examining two distinct acetyl-CoA producing enzymes: ACLY and ACSS2.
Not only will I investigate mTORC2’s role in regulating both ACLY and ACSS2 through phosphorylation, but
also for the first time, investigate mTORC2 loss in an acute setting using an auxin degron system, which is a
plant based endogenous degradation tag. With the completion of this proposed work, I strongly believe that a
more detailed and mechanistic understanding of hepatic signaling, and metabolism will be obtained, providing
targets which could ultimately be used to treat NAFLD and other metabolic diseases.
项目概要
Non-alcoholic fatty liver disease (NAFLD) currently effects around 30% of Americans and costs the U.S
每年约1030亿美元。然而,护理标准仍然是改变生活方式和肝脏
目前尚无 FDA 批准的疗法进行移植。 NAFLD 通常与不断上升的肥胖相关
在发达国家和发展中国家。雷帕霉素复合物 2 (mTORC2) 的哺乳动物靶标正在出现
作为碳水化合物和脂质代谢的中心枢纽,其激活与 NAFLD 相关
老鼠。这些最近的研究强调了 mTORC2 调节在小鼠高脂肪饮食期间的作用,
其中肝脏 mTORC2 消融对高脂肪诱导的肝脂肪变性具有保护作用。
然而,对人类 NAFLD 发病率影响最大的膳食补充剂是
碳水化合物,特别是果糖。而 mTORC2 消融对高脂饮食期间肝脏的保护作用
尽管人们对饮食进行了研究,但它对高碳水化合物饮食的影响却被忽视了。在这里,我将检查
mTORC2 能够防止高碳水化合物诱导的肝脂肪变性,正如之前所研究的那样
在高脂肪饮食的背景下出现。从机制上讲,我将研究肝脏 mTORC2 的作用
调节碳水化合物衍生的乙酰辅酶A的合成和利用,从而促进发病机制
非酒精性脂肪肝病。我将通过检查两种不同的乙酰辅酶A产生酶来实现这一目标:ACLY和ACSS2。
我不仅将研究 mTORC2 通过磷酸化调节 ACLY 和 ACSS2 的作用,而且
同样是第一次,使用生长素降解决定子系统研究急性环境中 mTORC2 的丢失,这是一个
基于植物的内源降解标签。随着这项拟议工作的完成,我坚信
将获得对肝脏信号传导和代谢的更详细和机制的了解,从而提供
最终可用于治疗 NAFLD 和其他代谢性疾病的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Anthony Haley其他文献
John Anthony Haley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Anthony Haley', 18)}}的其他基金
Elucidating the role of hepatic mTORC2 as a key regulator of carbohydrate metabolism in non-alcoholic fatty liver disease
阐明肝脏 mTORC2 作为碳水化合物代谢关键调节因子在非酒精性脂肪肝中的作用
- 批准号:
10548816 - 财政年份:2022
- 资助金额:
$ 3.4万 - 项目类别:
相似海外基金
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 3.4万 - 项目类别:
Continuing Grant
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 3.4万 - 项目类别:
Standard Grant
Collaborative Research: CDS&E: An experimentally validated, interactive, data-enabled scientific computing platform for cardiac tissue ablation characterization and monitoring
合作研究:CDS
- 批准号:
2245152 - 财政年份:2023
- 资助金额:
$ 3.4万 - 项目类别:
Standard Grant














{{item.name}}会员




